Form 4: Bayview Legacy Sells 100,000 Arteris Shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 100,000 shares of common stock for a weighted average price of $13.1045 per share.

Summary

• Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported the sale of 100,000 shares of common stock.
• The transaction occurred on October 6, 2025, at a weighted average sale price of $13.1045 per share.
• Shares were sold in multiple transactions with prices ranging from $12.50 to $13.85.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by K. Charles Janac, manager of Bayview Legacy, LLC, on March 5, 2025.
• Following the reported transaction, Bayview Legacy, LLC beneficially owns 9,739,071 shares of Arteris, Inc. common stock.
• K. Charles Janac, as the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and has filed a separate Form 4 for the same transaction.

Sentiment

Score: 4

Explanation: The sale by a 10% owner, even if pre-planned, can be interpreted as a slightly negative signal, though the 10b5-1 plan mitigates immediate concerns about management confidence.

Positives

• The transaction was made pursuant to a pre-established Rule 10b5-1 trading plan, indicating a scheduled sale rather than a reactive decision based on recent company performance.

Negatives

• A significant shareholder, Bayview Legacy, LLC, reduced its stake in Arteris, Inc. by 100,000 shares, which could be perceived negatively by the market.

Management Comments

• K. Charles Janac, as the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Related Party Transactions

• K. Charles Janac, the manager of Bayview Legacy, LLC, also filed a separate Form 4 reporting the same transaction, acknowledging his beneficial ownership and control over the shares.

Stakeholder Impact

• Shareholders may view the reduction in stake by a significant owner as a potential signal, though the pre-planned nature of the sale lessens its immediate impact.

Key Dates

Recommendation

The transaction is a pre-scheduled sale by a 10% owner under a Rule 10b5-1 plan, which typically indicates a planned liquidity event rather than a reaction to new information. While a sale by a significant holder can be a negative signal, the planned nature suggests it's not necessarily indicative of a change in fundamental outlook for the company. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future filings and company performance rather than reacting solely to this single, pre-arranged transaction.

Keywords

Arteris, AIP, Bayview Legacy, K. Charles Janac, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Shareholder